pantoprazole has been researched along with gastrins in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 11 (45.83) | 18.2507 |
| 2000's | 8 (33.33) | 29.6817 |
| 2010's | 4 (16.67) | 24.3611 |
| 2020's | 1 (4.17) | 2.80 |
| Authors | Studies |
|---|---|
| Christ, B; Hauschke, D; Ockert, D; Tuch, K | 1 |
| Dorrian, CA; Fullarton, GM; Harwood, J; Macdonald, AM; McColl, KE; Nujumi, AM | 1 |
| Broom, C; Hannan, A; Walt, RP; Weil, J | 1 |
| Hartmann, R; Huber, R; Lühmann, R; Marinis, E; Müller, P; Simon, B; Wurst, W | 1 |
| Bliesath, H; Bohnenkamp, W; Hartmann, M; Huber, R; Lühmann, R; Müller, P; Simon, B; Wurst, W | 1 |
| Gütz, H; Hüttemann, W; Schepp, W; Witzel, L | 1 |
| Londong, W | 1 |
| Brunner, G; Harke, U | 1 |
| Arnold, R | 1 |
| Arnold, R; Eissele, R; Fischer, R; Flüg, M; Koop, H; Kuly, S; Lühmann, R; Mönnikes, H; Rose, K; Schneider, A | 1 |
| Deprez, P; Escourrou, J; Fischer, R; Geldof, H; Maier, C; Saggioro, A | 1 |
| Bakke, I; Brenna, E; Qvigstad, G; Sandvik, AK; Waldum, HL | 1 |
| Bakke, I; Chen, D; Håkanson, R; Tostrup-Skogaker, N; Waldum, HL; Zhao, CM | 1 |
| Bardhan, KD; Bishop, AE; Cherian, P; Fischer, R; Lühmann, R; McCaldin, B; Morris, P; Ng, W; Perry, MJ; Polak, JM; Romanska, H; Rowland, A; Schneider, A; Thompson, M | 1 |
| Hase, S; Takeuchi, K | 1 |
| Mignon, M; Ramdani, A; Samoyeau, R | 1 |
| Bendheim, MØ; Martinsen, TC; Skogaker, NE; Waldum, HL | 1 |
| Bardhan, KD; Bishop, AE; Luehmann, R; McCaldin, B; Morris, P; Polak, JM; Romanska, HM; Rowland, A; Schaefer-Preuss, S; Thompson, M | 1 |
| Boyer, K; Tolia, V | 1 |
| Björnsson, E; Lindberg, G; Lindström, L; Niklasson, A; Simrén, M | 1 |
| Bakke, I; Chen, D; Erlandsen, SE; Fossmark, R; Qvigstad, G; Sandvik, AK | 1 |
| Hahm, KB; Han, YM; Hong, SP; Kim, EH; Park, JM | 1 |
| Ahlgren, U; Arbo, IB; Eriksson, M; Grong, E; Kulseng, BE; Mårvik, R; Nord, C | 1 |
| Dastghaib, S; Koohpeyma, F; Saki, F; Shams, M | 1 |
3 review(s) available for pantoprazole and gastrins
| Article | Year |
|---|---|
Effect of pantoprazole on 24-h intragastric pH and serum gastrin in humans.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Benzimidazoles; Dose-Response Relationship, Drug; Double-Blind Method; Enterochromaffin Cells; Female; Gastric Acid; Gastrins; Humans; Hydrogen-Ion Concentration; Injections, Intravenous; Male; Omeprazole; Pantoprazole; Prospective Studies; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Sulfoxides | 1994 |
Safety of proton pump inhibitors--an overview.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Benzimidazoles; Cytochrome P-450 Enzyme System; Disease Models, Animal; Drug Interactions; Enterochromaffin Cells; Gastrins; Humans; Lansoprazole; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Sulfoxides | 1994 |
[Proton pump inhibitors: Pantoprazole].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Enzyme Inhibitors; Gastric Acid; Gastrins; Humans; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides | 2002 |
9 trial(s) available for pantoprazole and gastrins
| Article | Year |
|---|---|
Effects of oral pantoprazole on 24-hour intragastric acidity and plasma gastrin profiles.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Benzimidazoles; Circadian Rhythm; Double-Blind Method; Gastric Acidity Determination; Gastrins; Humans; Male; Omeprazole; Pantoprazole; Sulfoxides | 1992 |
Effect of repeated oral administration of BY 1023/SK&F 96022--a new substituted benzimidazole derivative--on pentagastrin-stimulated gastric acid secretion and pharmacokinetics in man.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Adult; Benzimidazoles; Blood Pressure; Gastric Acid; Gastrins; Half-Life; Heart Rate; Humans; Hydrogen-Ion Concentration; Male; Omeprazole; Pantoprazole; Pentagastrin; Sulfoxides | 1990 |
Pantoprazole versus omeprazole in the treatment of acute gastric ulcers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Administration, Oral; Adult; Aged; Aged, 80 and over; Benzimidazoles; Double-Blind Method; Female; Gastrins; Humans; Male; Middle Aged; Omeprazole; Pain; Pantoprazole; Proton Pump Inhibitors; Stomach Ulcer; Sulfoxides | 1995 |
Long-term therapy with pantoprazole in patients with peptic ulceration resistant to extended high-dose ranitidine treatment.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Duodenal Ulcer; Enterochromaffin Cells; Esophagitis; Female; Gastrins; Humans; Longitudinal Studies; Male; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Ranitidine; Stomach Ulcer; Sulfoxides | 1994 |
Intragastric pH and serum gastrin during administration of different doses of pantoprazole in healthy subjects.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Gastric Acid; Gastrins; Humans; Hydrogen-Ion Concentration; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides | 1996 |
Maintenance therapy with pantoprazole 20 mg prevents relapse of reflux oesophagitis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Enzyme Inhibitors; Esophagitis, Peptic; Esophagoscopy; Female; Gastrins; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Patient Compliance; Prospective Studies; Proton Pump Inhibitors; Secondary Prevention; Sulfoxides | 1999 |
Pantoprazole therapy in the long-term management of severe acid peptic disease: clinical efficacy, safety, serum gastrin, gastric histology, and endocrine cell studies.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Cell Count; Drug Resistance; Enteroendocrine Cells; Enzyme Inhibitors; Female; Gastrins; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Recurrence; Sulfoxides | 2001 |
Effect of pantoprazole versus other proton pump inhibitors on 24-hour intragastric pH and basal acid output in Zollinger-Ellison syndrome.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Female; Gastric Acid; Gastric Acidity Determination; Gastrins; Humans; Lansoprazole; Male; Omeprazole; Pantoprazole; Prospective Studies; Proton Pump Inhibitors; Sulfoxides; Time Factors; Zollinger-Ellison Syndrome | 2002 |
Dyspeptic symptom development after discontinuation of a proton pump inhibitor: a double-blind placebo-controlled trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Chromogranin A; Double-Blind Method; Dyspepsia; Female; Gastric Acid; Gastrins; Humans; Male; Middle Aged; Pantoprazole; Placebos; Proton Pump Inhibitors; Severity of Illness Index; Statistics, Nonparametric; Surveys and Questionnaires; Sweden | 2010 |
12 other study(ies) available for pantoprazole and gastrins
| Article | Year |
|---|---|
Comparison of the ECL-cell frequency in the stomachs of 3 different rat strains.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Administration, Oral; Animals; Benzimidazoles; Cell Count; Enterochromaffin Cells; Female; Gastric Mucosa; Gastrins; Image Processing, Computer-Assisted; Omeprazole; Pantoprazole; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; Rats, Wistar; Species Specificity; Stomach; Sulfoxides | 1992 |
Helicobacter pylori and hypergastrinaemia during proton pump inhibitor therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Benzimidazoles; Duodenal Ulcer; Gastric Acidity Determination; Gastrins; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Pantoprazole; Pepsinogen A; Pepsinogens; Peptide Fragments; Sulfoxides | 1992 |
Pentagastrin-stimulated gastric acid secretion and pharmacokinetics following single and repeated intravenous administration of the gastric H+, K(+)-ATPase-inhibitor pantoprazole (BY1023/SK&F96022) in healthy volunteers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Benzimidazoles; Gastric Acid; Gastrins; Humans; Hydrogen-Ion Concentration; Male; Omeprazole; Pantoprazole; Pentagastrin; Single-Blind Method; Sodium-Potassium-Exchanging ATPase; Sulfoxides | 1990 |
Gastrin has a specific proliferative effect on the rat enterochromaffin-like cell, but not on the parietal cell: a study by elutriation centrifugation.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Benzimidazoles; Cell Division; Cell Fractionation; Centrifugation; Cytoplasmic Granules; Enterochromaffin Cells; Enzyme Inhibitors; Female; Gastric Mucosa; Gastrins; Histamine; Hyperplasia; Microscopy, Electron; Omeprazole; Pantoprazole; Parietal Cells, Gastric; Rats; Rats, Sprague-Dawley; Sulfoxides | 2000 |
Functionally impaired, hypertrophic ECL cells accumulate vacuoles and lipofuscin bodies. An ultrastructural study of ECL cells isolated from hypergastrinemic rats.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Benzimidazoles; Cell Division; Cell Size; Enterochromaffin-like Cells; Enzyme Inhibitors; Female; Gastric Acid; Gastric Mucosa; Gastrins; Histamine; Histamine Release; Histidine Decarboxylase; Hypertrophy; Lipofuscin; Microscopy, Electron; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rats; Rats, Sprague-Dawley; Secretory Vesicles; Stomach; Sulfoxides; Time Factors; Vacuoles | 2001 |
Antral G cells in rats during dosing with a PPAR alpha agonist: a morphometric and immunocytochemical study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Benzimidazoles; Clofibric Acid; Fibric Acids; Gastrin-Secreting Cells; Gastrins; Immunohistochemistry; Male; Microscopy, Immunoelectron; Omeprazole; Pantoprazole; Peroxisome Proliferators; Peroxisomes; Proton Pump Inhibitors; Pyloric Antrum; Rats; Rats, Inbred F344; Receptors, Cytoplasmic and Nuclear; Sulfoxides; Transcription Factors | 2003 |
Pantoprazole in severe acid-peptic disease: the effectiveness and safety of 5 years' continuous treatment.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Cell Count; Enteroendocrine Cells; Female; Gastric Mucosa; Gastrin-Secreting Cells; Gastrins; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Peptic Ulcer; Sulfoxides | 2005 |
Long-term proton pump inhibitor use in children: a retrospective review of safety.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Child; Child, Preschool; Esophagitis; Female; Gastrins; Humans; Lansoprazole; Liver Function Tests; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Retrospective Studies; Vitamin B 12 | 2008 |
Regulated endocrine-specific protein 18 (RESP18) is localized to and regulated in A-like cells and G-cells in rat stomach.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Benzodiazepinones; Fasting; Feeding Behavior; Gastric Mucosa; Gastrin-Secreting Cells; Gastrins; Gene Expression Regulation; Ghrelin; Immunohistochemistry; Intestine, Small; Nerve Tissue Proteins; Octreotide; Pantoprazole; Phenylurea Compounds; Pyloric Antrum; Rats; Rats, Sprague-Dawley; RNA, Messenger; Stomach | 2012 |
Paradoxically augmented anti-tumorigenic action of proton pump inhibitor and GastrininAPCMin/+ intestinal polyposis model.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Active Transport, Cell Nucleus; Animals; Antineoplastic Agents; Apoptosis; beta Catenin; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Cyclooxygenase 2; Gastrins; Gene Expression Regulation, Neoplastic; Inflammation; Intestinal Polyposis; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neoplasm Transplantation; Neoplasms, Experimental; Pantoprazole; Platelet Endothelial Cell Adhesion Molecule-1; Proton Pump Inhibitors; Signal Transduction; Tumor Necrosis Factor-alpha | 2014 |
The effect of hypergastrinemia following sleeve gastrectomy and pantoprazole on type 2 diabetes mellitus and beta-cell mass in Goto-Kakizaki rats.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Combined Modality Therapy; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Gastrectomy; Gastrins; Hormones; Insulin-Secreting Cells; Male; Pantoprazole; Rats | 2018 |
Pantoprazole-Induced Bone Loss through Gastrin Secretion: A Stereological Study.
Topics: Alkaline Phosphatase; Animals; Bone Diseases, Metabolic; Gastrins; Male; Octreotide; Pantoprazole; Parathyroid Hormone; Rats | 2023 |